Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet Rich Plasma for Non-scarring Alopecia in Women
NCT03689452Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Oct 2018
- Primary completion
- Jun 2019
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Randomised, double-blind trial of autologous platelet-rich plasma in androgenetic alopecia (AGA), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoints: Number of Participants With Improvement at 24 weeks and Change in Hair Caliber Using Trichoscopy at 24 weeks. Started Oct 2018; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT03689452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03689452.